First Midwest Bank Trust Division’s Galmed Pharmaceuticals GLMD Stock Holding History

First Midwest Bank Trust Division’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-916	Closed	-$788K	–	366
2019 Q3	$788K	Hold	916	–	–	0.11%	194
2019 Q2	$1.21M	Sell	916 -74	-7%	-$95.4K	0.17%	143
2019 Q1	$1.46M	Sell	990 -204	-17%	-$297K	0.2%	131
2018 Q4	$1.47M	Buy	1,194 +1,062	+805%	+$1.85M	0.22%	119
2018 Q3	$323K	Hold	132	–	–	0.04%	347
2018 Q2	$282K	Buy	+132	New	+$191K	0.04%	375

Other funds holding GLMD

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

RCG

Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

First Midwest Bank Trust Division's GLMD Position: Q4 2019 in Review

First Midwest Bank Trust Division sold out of Galmed Pharmaceuticals (GLMD) in Q4 2019, closing a stake of 916 shares — an estimated $788K sold.

First Midwest Bank Trust Division first reported a position in GLMD in Q2 2018 and held it in 6 quarters. The position peaked at $1.47M in Q4 2018. 31 funds tracked by Wall St. Rank hold GLMD as of Q4 2019.

First Midwest Bank Trust Division reported no remaining Galmed Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
First Midwest Bank Trust Division sold 916 Galmed Pharmaceuticals shares in Q4 2019, an estimated $788K.
First Midwest Bank Trust Division first reported a position in Galmed Pharmaceuticals in Q2 2018 and held it in 6 quarters.
First Midwest Bank Trust Division's Galmed Pharmaceuticals position peaked at $1.47M in Q4 2018.
31 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2019.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2019, filed 23 Jan 2020.